Skip to main content
Top
Published in: Internal and Emergency Medicine 6/2021

01-09-2021 | Idiopathic Pulmonary Fibrosis | IM - ORIGINAL

Association between C-reactive protein and carotid plaque in mild-to-moderate idiopathic pulmonary fibrosis

Authors: Andrea Sonaglioni, Antonella Caminati, Roberto Lipsi, Michele Lombardo, Sergio Harari

Published in: Internal and Emergency Medicine | Issue 6/2021

Login to get access

Abstract

An association between C-reactive protein (CRP) levels and carotid plaque has never been investigated in idiopathic pulmonary fibrosis (IPF). The aim of this study was to evaluate the extent of carotid atherosclerosis in mild-to-moderate IPF and to assess its relationship to serum CRP. This observational retrospective case–control study included 60 consecutive IPF patients (73.8 ± 6.6 years, 45 males) and 60 matched controls, examined between Sep 2017 and Jan 2019. All patients underwent CRP assessment and a carotid Doppler ultrasonography. CRP levels were significantly higher in IPF patients than controls (0.2 ± 0.09 mg/dl vs 0.09 ± 0.04 mg/dl, p < 0.0001). A total of 46 plaques were detected, with higher prevalence in IPF patients than controls (38 vs 8, p < 0.0001). On univariate logistic regression the main variables independently associated with carotid plaque were: age (HR 1.09, 95% CI 1.03–1.16, p = 0.006), hypertension duration (HR 1.05, 95% CI 1.01–1.09, p = 0.01), diabetes duration (HR 1.09, 95% CI 1.01–1.18, p = 0.03), LDL-cholesterol (HR 1.07, 95% CI 1.04–1.10, p < 0.0001) and finally CRP levels (HR 1.73, 95% CI 0.59–5.00, p < 0.0001). Multivariate logistic regression analysis revealed that LDL-cholesterol (HR 1.05, 95% CI 1.01–1.08, p = 0.009) and CRP levels (HR 1.43, 95% CI 0.39–5.19, p < 0.0001) retained statistical significance. Common carotid artery-intima media thickness was significantly correlated with CRP levels in IPF patients (r = 0.86). SerumCRP might represent both an early marker and a potential therapeutic target for carotid atherosclerosis in mild-to-moderate IPF.
Literature
1.
go back to reference Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44-68PubMedCrossRef Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44-68PubMedCrossRef
2.
3.
go back to reference Dalleywater W, Powell HA, Hubbard RB, Navaratnam V (2015) Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Chest 147:150–156PubMedCrossRef Dalleywater W, Powell HA, Hubbard RB, Navaratnam V (2015) Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Chest 147:150–156PubMedCrossRef
4.
go back to reference van Cleemput J, Sonaglioni A, Wuyts WA et al (2019) Idiopathic pulmonary fibrosis for cardiologists: differential diagnosis, cardiovascular comorbidities, and patient management. Adv Ther 36:298–317PubMedCrossRef van Cleemput J, Sonaglioni A, Wuyts WA et al (2019) Idiopathic pulmonary fibrosis for cardiologists: differential diagnosis, cardiovascular comorbidities, and patient management. Adv Ther 36:298–317PubMedCrossRef
5.
go back to reference Nathan SD, Noble PW, Tuder RM (2007) Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175:875–880PubMedCrossRef Nathan SD, Noble PW, Tuder RM (2007) Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175:875–880PubMedCrossRef
6.
go back to reference Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:746–752PubMedCrossRef Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:746–752PubMedCrossRef
7.
go back to reference Nathan SD, Basavaraj A, Reichner C et al (2010) Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med 104:1035–1041PubMedCrossRef Nathan SD, Basavaraj A, Reichner C et al (2010) Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med 104:1035–1041PubMedCrossRef
8.
go back to reference Shibata Y, Watanabe T, Osaka D et al (2011) Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 8:514–522PubMedPubMedCentralCrossRef Shibata Y, Watanabe T, Osaka D et al (2011) Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 8:514–522PubMedPubMedCentralCrossRef
9.
go back to reference Caminati A, Lonati C, Cassandro R et al (2019) Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respir Rev 28:190044PubMedCrossRef Caminati A, Lonati C, Cassandro R et al (2019) Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respir Rev 28:190044PubMedCrossRef
10.
11.
go back to reference Ridker PM, Haughie P (1998) Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med 46:391–395PubMed Ridker PM, Haughie P (1998) Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med 46:391–395PubMed
12.
go back to reference Koenig W, Sund M, Fröhlich M et al (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242PubMedCrossRef Koenig W, Sund M, Fröhlich M et al (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242PubMedCrossRef
13.
go back to reference Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565PubMedCrossRef Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565PubMedCrossRef
14.
go back to reference Alageel S, Gulliford MC (2019) Health checks and cardiovascular risk factor values over six year’s follow-up: matched cohort study using electronic health records in England. PLoS Med 16:e1002863PubMedPubMedCentralCrossRef Alageel S, Gulliford MC (2019) Health checks and cardiovascular risk factor values over six year’s follow-up: matched cohort study using electronic health records in England. PLoS Med 16:e1002863PubMedPubMedCentralCrossRef
15.
go back to reference Harari S, Cereda F, Pane F et al (2019) Lung cryobiopsy for the diagnosis of interstitial lung diseases: a series contribution to a debated procedure. Medicina 55:606PubMedCentralCrossRef Harari S, Cereda F, Pane F et al (2019) Lung cryobiopsy for the diagnosis of interstitial lung diseases: a series contribution to a debated procedure. Medicina 55:606PubMedCentralCrossRef
16.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470PubMedCrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470PubMedCrossRef
17.
go back to reference Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28:1-39.e14PubMedCrossRef Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28:1-39.e14PubMedCrossRef
18.
go back to reference Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 29:277–314CrossRefPubMed Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 29:277–314CrossRefPubMed
19.
go back to reference Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr 23:685–788PubMedCrossRef Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr 23:685–788PubMedCrossRef
20.
go back to reference Stein JH, Korcarz CE, Hurst RT et al (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr 21:93–190PubMedCrossRef Stein JH, Korcarz CE, Hurst RT et al (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr 21:93–190PubMedCrossRef
21.
go back to reference Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ (1988) Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg 29:676–681 Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ (1988) Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg 29:676–681
22.
go back to reference Joakimsen O, Bønaa KH, Stensland-Bugge E (1997) Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology. The Tromsø Study. Stroke 28:2201–2207PubMedCrossRef Joakimsen O, Bønaa KH, Stensland-Bugge E (1997) Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology. The Tromsø Study. Stroke 28:2201–2207PubMedCrossRef
23.
go back to reference AIUM (2016) Practice parameter for the performance of an ultrasound examination of the extracranial cerebrovascular system. J Ultrasound Med 35:1–11 AIUM (2016) Practice parameter for the performance of an ultrasound examination of the extracranial cerebrovascular system. J Ultrasound Med 35:1–11
24.
go back to reference Bai CH, Chen JR, Chiu HC, Pan WH (2007) Lower blood flow velocity, higher resistance index, and larger diameter of extracranial carotid arteries are associated with ischemic stroke independently of carotid atherosclerosis and cardiovascular risk factors. J Clin Ultrasound 35:322–330PubMedCrossRef Bai CH, Chen JR, Chiu HC, Pan WH (2007) Lower blood flow velocity, higher resistance index, and larger diameter of extracranial carotid arteries are associated with ischemic stroke independently of carotid atherosclerosis and cardiovascular risk factors. J Clin Ultrasound 35:322–330PubMedCrossRef
25.
go back to reference Collaborators NASCET, Barnett HJM, Taylor DW et al (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445–453CrossRef Collaborators NASCET, Barnett HJM, Taylor DW et al (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445–453CrossRef
26.
go back to reference Kreuter M, Ehlers-Tenenbaum S, Palmowski K et al (2016) Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS ONE 11:e0151425PubMedPubMedCentralCrossRef Kreuter M, Ehlers-Tenenbaum S, Palmowski K et al (2016) Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS ONE 11:e0151425PubMedPubMedCentralCrossRef
27.
go back to reference Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J37:2129–2200CrossRef Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J37:2129–2200CrossRef
28.
go back to reference Hubbard RB, Smith C, Le Jeune I, Gribbin J, Fogarty AW (2008) The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 178:1257–1261PubMedCrossRef Hubbard RB, Smith C, Le Jeune I, Gribbin J, Fogarty AW (2008) The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 178:1257–1261PubMedCrossRef
29.
go back to reference Randrianarisoa E, Rietig R, Jacob S et al (2015) Normal values for intima-media thickness of the common carotid artery–an update following a novel risk factor profiling. Vasa 44:444–450PubMedCrossRef Randrianarisoa E, Rietig R, Jacob S et al (2015) Normal values for intima-media thickness of the common carotid artery–an update following a novel risk factor profiling. Vasa 44:444–450PubMedCrossRef
30.
go back to reference Schroeder EB, Welch VL, Evans GW, Heiss G (2005) Impaired lung function and subclinical atherosclerosis. The ARIC study. Atherosclerosis 180:367–373PubMedCrossRef Schroeder EB, Welch VL, Evans GW, Heiss G (2005) Impaired lung function and subclinical atherosclerosis. The ARIC study. Atherosclerosis 180:367–373PubMedCrossRef
31.
go back to reference Iwamoto H, Yokoyama A, Kitahara Y et al (2009) Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 179:35–40PubMedCrossRef Iwamoto H, Yokoyama A, Kitahara Y et al (2009) Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 179:35–40PubMedCrossRef
32.
go back to reference Barr RG, Ahmed FS, Carr JJ et al (2012) Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA lung Study. Eur Respir J 39:846–854PubMedCrossRef Barr RG, Ahmed FS, Carr JJ et al (2012) Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA lung Study. Eur Respir J 39:846–854PubMedCrossRef
33.
go back to reference O’Leary DH, Polak JF (2002) Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90:18L-21LPubMedCrossRef O’Leary DH, Polak JF (2002) Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90:18L-21LPubMedCrossRef
34.
go back to reference Ebrahim S, Papacosta O, Whincup P et al (1999) Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British regional heart study. Stroke 30:841–850PubMedCrossRef Ebrahim S, Papacosta O, Whincup P et al (1999) Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British regional heart study. Stroke 30:841–850PubMedCrossRef
35.
go back to reference Rothwell PM (2000) Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc Dis 10:21–33PubMedCrossRef Rothwell PM (2000) Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc Dis 10:21–33PubMedCrossRef
36.
go back to reference Polak JF, Shemanski L, O’Leary DH et al (1998) Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older cardiovascular health study. Radiology 208:649–654PubMedCrossRef Polak JF, Shemanski L, O’Leary DH et al (1998) Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older cardiovascular health study. Radiology 208:649–654PubMedCrossRef
37.
go back to reference Mathiesen EB, Joakimsen O, Bønaa KH (2001) Prevalence of and risk factors associated with carotid artery stenosis: the Tromsø study. Cerebrovasc Dis 12:44–51PubMedCrossRef Mathiesen EB, Joakimsen O, Bønaa KH (2001) Prevalence of and risk factors associated with carotid artery stenosis: the Tromsø study. Cerebrovasc Dis 12:44–51PubMedCrossRef
38.
39.
go back to reference Dropiński J, Szczeklik W, Wegrzyn W (2003) Increased carotid artery intima-media thickness as an indicator of the onset of atherosclerosis in patients with connective tissue systemic diseases. Kardiol Pol 59:475–483PubMed Dropiński J, Szczeklik W, Wegrzyn W (2003) Increased carotid artery intima-media thickness as an indicator of the onset of atherosclerosis in patients with connective tissue systemic diseases. Kardiol Pol 59:475–483PubMed
40.
go back to reference Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168PubMedCrossRef Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168PubMedCrossRef
41.
go back to reference Puz P, Lasek-Bal A, Ziaja D, Kazibutowska Z, Ziaja K (2013) Inflammatory markers in patients with internal carotid artery stenosis. Arch Med Sci 9:254–260PubMedPubMedCentralCrossRef Puz P, Lasek-Bal A, Ziaja D, Kazibutowska Z, Ziaja K (2013) Inflammatory markers in patients with internal carotid artery stenosis. Arch Med Sci 9:254–260PubMedPubMedCentralCrossRef
42.
go back to reference Wang TJ, Nam BH, Wilson PW et al (2002) Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham heart study. Arterioscler Thromb Vasc Biol 22:1662–1667PubMedCrossRef Wang TJ, Nam BH, Wilson PW et al (2002) Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham heart study. Arterioscler Thromb Vasc Biol 22:1662–1667PubMedCrossRef
43.
go back to reference Leonsson M, Hulthe J, Johannsson G et al (2003) Increased Interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness. Clin Endocrinol 59:242–250CrossRef Leonsson M, Hulthe J, Johannsson G et al (2003) Increased Interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness. Clin Endocrinol 59:242–250CrossRef
44.
go back to reference Aso Y, Okumura K, Takebayashi K, Wakabayashi S, Inukai T (2003) Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 26:2622–2627PubMedCrossRef Aso Y, Okumura K, Takebayashi K, Wakabayashi S, Inukai T (2003) Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 26:2622–2627PubMedCrossRef
45.
go back to reference Rothman KJ, Greenland S (1998) Causation and causal inference. In: Rothman KJ, Greenland S (eds) Modern epidemiology. Lippincott-Raven, Philadelphia, pp 7–28 Rothman KJ, Greenland S (1998) Causation and causal inference. In: Rothman KJ, Greenland S (eds) Modern epidemiology. Lippincott-Raven, Philadelphia, pp 7–28
46.
go back to reference Graziani F, Varone F, Crea F, Richeldi L (2018) Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis. Eur J Heart Fail 20:1385–1391PubMedCrossRef Graziani F, Varone F, Crea F, Richeldi L (2018) Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis. Eur J Heart Fail 20:1385–1391PubMedCrossRef
47.
go back to reference Satoh H, Kurishima K, Ishikawa H, Ohtsuka M (2006) Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med 260:429–434PubMedCrossRef Satoh H, Kurishima K, Ishikawa H, Ohtsuka M (2006) Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med 260:429–434PubMedCrossRef
48.
go back to reference Kinder BW, Brown KK, McCormack FX et al (2009) Serum surfactant protein—a is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 135:1557–1563PubMedPubMedCentralCrossRef Kinder BW, Brown KK, McCormack FX et al (2009) Serum surfactant protein—a is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 135:1557–1563PubMedPubMedCentralCrossRef
49.
go back to reference Barlo NP, van Moorsel CH, Ruven HJ, Zanen P, van den Bosch JM, Grutters JC (2009) Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 26(2):155–161PubMed Barlo NP, van Moorsel CH, Ruven HJ, Zanen P, van den Bosch JM, Grutters JC (2009) Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 26(2):155–161PubMed
50.
Metadata
Title
Association between C-reactive protein and carotid plaque in mild-to-moderate idiopathic pulmonary fibrosis
Authors
Andrea Sonaglioni
Antonella Caminati
Roberto Lipsi
Michele Lombardo
Sergio Harari
Publication date
01-09-2021
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 6/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02607-6

Other articles of this Issue 6/2021

Internal and Emergency Medicine 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine